The content on this site is intended for healthcare professionals only
Treatment of myelodysplastic syndrome: Expert Roundtable
Treatment of poor prognosis AML: Expert roundtable
Treatment of elderly multiple myeloma patients: Expert Roundtable
Management of elderly lymphoma patients: Expert Roundtable
Psycho-social aspects of treating elderly patients: Expert roundtable
Treatment of elderly or unfit CLL patients: Expert Roundtable
Comprehensive geriatric assessment: Expert roundtable
Geriatric oncology
Treatment of elderly MDS patients
Autologous stem cell transplants for multiple myeloma
Benefits of maintenance therapy for multiple myeloma
Acute myeloid leukaemia: the challenges
Improving patient compliance with treatment schedules
Main issues in treating elderly patients with myeloma
Treatment of elderly non-Hodgkin’s lymphoma patients
Maintenance therapy for multiple myeloma
Use of comorbidities to determine CLL patient fitness
Therapy options and the future for multiple myeloma
Advances in myelodysplastic syndrome
Cytogenetic scoring system for MDS
Clinical trial design for research into cancer in the elderly
Treatment options for acute myeloid leukaemia
Addition of thalidomide to myeloma treatment improves response in elderly patients
Treatment options for elderly CLL patients
Management of haematological cancer in the elderly
Different options for elderly CLL patients
Blood cancer in the elderly European expert forum
Treatment barriers for elderly patients
Assessing psycho-oncology
Treatments for elderly CLL patients
Parameters for diagnosing MDS
Blood cancer in the elderly European expert forum (IT)
